FSR vs PSTV
FSR (FSR) versus Plus Therapeutics Inc (PSTV) — a side-by-side from cached financials, not a winner call.
FSR (FSR) common stock.
Plus Therapeutics Inc (PSTV) is a biotechnology company listed on NASDAQ.
FSR does not have a complete income-statement cache yet.
Latest reported PSTV revenue for 2024-12-31 was $5.8M. Net income was -$13.0M. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
Not investment advice. Open the FSR and PSTV stock pages for the full models.
Not investment advice.